Our formulation experience includes working with a broad range of therapeutic candidates that vary in molecular size, complexity and production processes. The length-breadth-depth of our experience includes:

Therapeutic Agents	Structural Complexities	Manufacturing Systems
Monoclonal antibodies	Single and multiple chain	Synthetic
Other proteins	High and low molecular weight	E.coli
Peptides	Conjugated molecular entities	CHO
Oligonucleotides	Glycosylated and non-glycosylated	Baculovirus
Conjugates	Virus-like particles	Hybridoma
Viral and non-viral gene vectors	Lectins	Plant
Vaccines		Fungal
Small molecules
Synthetic new chemical entities

Our ultimate goal: deliver a product formulation that is stable when exposed to conditions such as time, temperature, light, and humidity.

At Formatech, formulations are rationally developed to:

• Enhance solubility/absorption/bioavailability
• Eliminate or minimize product instabilities
• Ensure appropriate clinical presentation
  

During formulation development, we leverage the knowledge gained from our preformulation programs — Stability FingerPrinting® and Stability Profiling™ — to assist our clients in developing a stable dosage form. At this stage, generally recognized as safe (GRAS) excipients are screened to address product-specific instabilities and our clients’ product specification requirements.

To request more information on our formulation services, please click here.
 

Case Study – Increase Bioavailability

---

Case Study – Formulation/Dosage Form Change

---

Case Study – Analytical Development